$SRPT News

Sarepta Therapeutics to Present at Upcoming Investor Conferences

Sarepta Therapeutics to Announce Third Quarter 2026 Financial Results

Sarepta Therapeutics Presents New Preclinical Data Demonstrating Robust Knockdown of Pathogenic DMPK RNA in the Nucleus with SRP-1003 in DM1 at 2026 Oligonucleotide Therapeutics Society Annual Meeting

RBC Capital Maintains Sector Perform on Sarepta Therapeutics, Lowers Price Target to $17

Jim Cramer Explains His Hesitation Over Sarepta (SRPT) Therapeutics

HC Wainwright & Co. Reiterates Sell on Sarepta Therapeutics, Maintains $5 Price Target

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

JP Morgan Maintains Neutral on Sarepta Therapeutics, Lowers Price Target to $20

Sarepta Therapeutics Presents New Data at 2026 World Muscle Society Annual Congress Demonstrating Safety and Clinically Meaningful Functional Benefit of ELEVIDYS (delandistrogene moxeparvovec) in Older Ambulatory Patients with Duchenne

Sarepta Therapeutics Presents New Data At 31st Annual Congress Of WMS That Provide Evidence Of Clinically Meaningful Functional Benefit Of ELEVIDYS In Older Ambulatory Patients With Duchenne Muscular Dystrophy

Needham Reiterates Underperform on Sarepta Therapeuticsto Underperform

Why Sarepta Therapeutics (SRPT) Is Down 7.2% After AAVrh74 Patent Peace With REGENXBIO And UPenn

Sarepta Therapeutics Announces Presentations at 2026 World Muscle Society Annual Congress

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 27th Annual Neuromuscular Study Group Scientific Meeting

Sarepta Sees ELEVIDYS Demand Stabilizing as FSHD, DM1 Readouts Near

Sarepta Therapeutics, Inc. (SRPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

A Rivals Clinical Stumble Sends Sarepta Therapeutics Stock Lower

Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2026-2027 Academic Year

Sarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Sarepta: A Prove-It Story Now Defined By ELEVIDYS Execution